Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Arthritis and Rheumatism
|
September 18, 2003
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice
Kim W McIntyre, David J Shuster, Kathleen M Gillooly, et al.
Blood
|
April 15, 1997
Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sites
C L Ramos, E J Kunkel, M B Lawrence, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2002
C-3 Amido-indole cannabinoid receptor modulators
John Hynes, Katerina Leftheris, Hong Wu, et al.
Plos One
|
July 26, 2017
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M Gillooly, Claudine Pulicicchio, Mark A Pattoli, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors
Makonen Belema, Amy Bunker, Van N Nguyen, et al.
Journal of Leukocyte Biology
|
August 5, 2006
A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice
Liya Kang, Kim W McIntyre, Kathleen M Gillooly, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties
Stephen T Wrobleski, Ping Chen, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase
James Kempson, Junqing Guo, Jagabandhu Das, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis
Alaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Journal of Medicinal Chemistry
|
September 30, 2005
5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase
Chunjian Liu, Stephen T Wrobleski, James Lin, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Arthritis and Rheumatism
|
September 18, 2003
A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice
Kim W McIntyre, David J Shuster, Kathleen M Gillooly, et al.
Blood
|
April 15, 1997
Differential effect of E-selectin antibodies on neutrophil rolling and recruitment to inflammatory sites
C L Ramos, E J Kunkel, M B Lawrence, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 6, 2002
C-3 Amido-indole cannabinoid receptor modulators
John Hynes, Katerina Leftheris, Hong Wu, et al.
Plos One
|
July 26, 2017
Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care
Kathleen M Gillooly, Claudine Pulicicchio, Mark A Pattoli, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 2, 2007
Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors
Makonen Belema, Amy Bunker, Van N Nguyen, et al.
Journal of Leukocyte Biology
|
August 5, 2006
A selective small molecule agonist of the melanocortin-1 receptor inhibits lipopolysaccharide-induced cytokine accumulation and leukocyte infiltration in mice
Liya Kang, Kim W McIntyre, Kathleen M Gillooly, et al.
Journal of Medicinal Chemistry
|
May 16, 2003
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties
Stephen T Wrobleski, Ping Chen, John Hynes, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 21, 2009
Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IkappaB kinase
James Kempson, Junqing Guo, Jagabandhu Das, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 20, 2010
Imidazo[4,5-d]thiazolo[5,4-b]pyridine based inhibitors of IKK2: synthesis, SAR, PK/PD and activity in a preclinical model of rheumatoid arthritis
Alaric J Dyckman, Charles M Langevine, Claude Quesnelle, et al.
Journal of Medicinal Chemistry
|
September 30, 2005
5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase
Chunjian Liu, Stephen T Wrobleski, James Lin, et al.
Page
of 5